Table 1

Baseline characteristics of evaluable patients

PlaceboRLX 60RLX 600P
No. of patients445049
Mean age (yr range)66 (51–79)66 (43–81)67 (51–80)0.920
Mean yr postmenopause (range)16 (2–42)17 (2–39)17 (0–34)0.941
Mean weight (kg)70.568.268.50.681
Patients with hysterectomy (% yes)22.718.014.30.573
Previous HRT use (% yes)25.022.020.40.866
Tumor type [n (%)]0.389
 Invasive43 (97.7)49 (98.0)49 (100)
 Other0 (0.0)1 (2.0)0 (0.0)
 Unspecified1 (2.3)0 (0.0)0 (0.0)
Stage of diagnosis [n (%)]0.943
 Stage I33 (75.0)38 (76.0)34 (69.4)
 Stage II9 (20.5)10 (20.0)13 (26.5)
 Unspecified2 (4.5)2 (4.0)2 (4.1)
Family breast cancer historya (% yes)26.010.218.20.126
  • a At least one primary relative (mother, sister).